Syngene: Your trusted CRO/CDMO across Small & Large Molecules

Syngene International Ltd is an integrated contract research, development and manufacturing services company serving the global pharma, biotech, nutrition, animal health, consumer goods and specialty chemical sectors.

Our 4200 scientists have both the skills and the capability to deliver great science, ensure robust data management, IP security and quality manufacturing, at speed, to improve time-to-market and lower the cost of innovation.

With 1.9 Mn sq ft of specialist discovery, development and manufacturing facilities, Syngene offers dedicated research facilities for several of its key clients including Amgen, Baxter, Bristol-Myers Squibb and Herbalife. We also work with biotech companies pursuing leading-edge science, and MNCs such as GSK and Merck KGaA.

Currently, we have >360 active clients across US, Europe, Japan, India and the rest of the world, and 400+ patent credits where we have been recognized as co-inventors by our clients.

Our Integrated & End-to-End Services

Small Molecules:

Discovery:  Chemistry, Biology, Safety Assessment, Research Informatics

Development: Chemical Development, Formulation Development, Analytical Development, Clinical Development

Manufacturing:  Commercial manufacturing

Large Molecules:

Discovery: Molecular Biology, Protein Sciences,  Cell line Development and Analysis, Antibody Generation

Development & Manufacturing: Development and Manufacturing Services, Analytical Characterization and Quality Control, Viral Testing and Clearance, Bioanalytical Laboratory Services.

SynVent Integrated Drug Discovery:

SynVent is Syngene’s platform for fully integrated therapeutic discovery and development across large and small molecules.  SynVent Integrated Drug Discovery (IDD) services are designed to provide the most effective and efficient means to conduct target validation, translational interrogation, therapeutic discovery, and preclinical development for our clients.

Executing End-to-End (E2E) discovery programs in collaboration with or on behalf of clients, SynVent IDD delivers exponential value through co-localization of world-class scientific teams across the discovery continuum, adhering to R&D timescales that are benchmarked to industry gold standards.

Other Modalities we deal in:

Peptides, Oligonucleotides, ADCs, PROTACs, CAR-T

Our Dedicated Centers:

Our Dedicated Centers offer dedicated multi-disciplinary scientific teams, support personnel, and a tailormade ring-fenced and fire-walled infrastructure as per client specifications to support their R&D  goals.

Syngene’s unique business model allows us to offer R&D services that are flexible and are designed to suit our client’s needs. Starting with a single service (component play), our client engagement gradually leads to an expanded scope of services (cluster play) and eventually into an integrated play, where we engage across multiple platforms, including setting up Dedicated Centers.

Our assurance of Quality

Syngene delivers its services based on the highest quality management principles including standards/ guidelines mentioned below:

• GMP as per Schedule – M of Drugs and Cosmetics Act (India)
• ICH Series Guidelines
• EU-GMP
• Japan GMP
• 21 CFR parts 11, 210, 211, 620 and 820
• OECD Guidelines
• New Drugs and Clinical Trials Rules, 2019
• ISO 9001:2015
• ISO 13485:2016